Collegium Pharmaceutical (COLL) Concludes Q4 2025 Earnings Call
$COLL Q4 2025 Earnings Call Concludes Amid Market Anticipation Key Takeaways Collegium Pharmaceutical, Inc. (COLL) held its **Q4 2025** earnings call presentation, as scheduled, to discuss its financial performance and operational updates. (Source: Collegium Pharmaceutical) The presentation covered the company’s performance for the quarter ending **December 31, 2025**, typically including revenue, net income, and strategic […]
Collegium Pharmaceutical (COLL) Concludes Q4 2025 Earnings Call Read More Β»
